Scopolamine and Depression: A Role for Muscarinic Antagonism?

E-ISSN： 1996-3181|13|4|673-683

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.13, Iss.4, 2014-06, pp. : 673-683

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Loss of anti-cataleptic effect of scopolamine in mice lacking muscarinic acetylcholine receptor subtype 4

By Karasawa H. Taketo M.M. Matsui M.

European Journal of Pharmacology, Vol. 468, Iss. 1, 2003-05 ,pp. : 15-19

Elsevier

Access to resources Recommend Favorite

Antagonism in Opioid Peptides: the Role of Conformation

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 1, 2004-01 ,pp. : 147-157

Bentham Science Publishers

Access to resources Recommend Favorite

Role of cholinergic receptors in locomotion induced by scopolamine and oxotremorine-M

By Chintoh A. Fulton J. Koziel N. Aziz M. Sud M. Yeomans J.S.

Pharmacology Biochemistry and Behavior, Vol. 76, Iss. 1, 2003-08 ,pp. : 53-61

Elsevier

Access to resources Recommend Favorite

Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism

By Gray A.M. Connick J.H.

European Journal of Pharmacology, Vol. 362, Iss. 2, 1998-12 ,pp. : 127-136

Elsevier

Access to resources Recommend Favorite

Binding Modes and Pharmacophoric Features of Muscarinic Antagonism and &bgr;2 Agonism (MABA) Conjugates

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 14, 2013-01 ,pp. : 1650-1655

Bentham Science Publishers

Access to resources Recommend Favorite